Literature DB >> 10873774

A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems.

J L Adam1, M W Briggs, D J McCance.   

Abstract

The E5 gene of human papillomavirus type 16 encodes a highly hydrophobic membrane protein previously shown to inhibit endosomal acidification, presumably by binding to the 16-kDa pore-forming subunit of the vacuolar H(+)-ATPase (v-ATPase). The role of this interaction in the disruption of v-ATPase activity was explored through extensive mutagenesis of E5 to identify residues that mediate binding to the 16-kDa subunit. Coimmunoprecipitations revealed that the hydrophobic span between residues 41 and 54 is primarily responsible for this interaction and can be replaced with random hydrophobic amino acids. Studies using mutated 16-kDa proteins indicated that the fourth transmembrane domain of the pore subunit mediates binding to E5. Analysis of the E5 mutants in a yeast expression system revealed that several mutants that retained the capacity to bind to the 16-kDa subunit in COS-1 cells failed to disrupt vacuolar acidification. These data argue that E5 binding to the pore subunit is not sufficient for the associated activity of disruption of v-ATPase function. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873774     DOI: 10.1006/viro.2000.0376

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  16 in total

1.  The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.

Authors:  Frank A Suprynowicz; Ewa Krawczyk; Jess D Hebert; Sawali R Sudarshan; Vera Simic; Christopher M Kamonjoh; Richard Schlegel
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

2.  The canine papillomavirus e5 protein signals from the endoplasmic reticulum.

Authors:  Rachel Condjella; Xuefeng Liu; Frank Suprynowicz; Hang Yuan; Sawali Sudarshan; Yuhai Dai; Richard Schlegel
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

3.  The HPV-16 E5 protein represses expression of stress pathway genes XBP-1 and COX-2 in genital keratinocytes.

Authors:  Sawali R Sudarshan; Richard Schlegel; Xuefeng Liu
Journal:  Biochem Biophys Res Commun       Date:  2010-08-03       Impact factor: 3.575

4.  Endoplasmic reticulum-localized human papillomavirus type 16 E5 protein alters endosomal pH but not trans-Golgi pH.

Authors:  Gary L Disbrow; John A Hanover; Richard Schlegel
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

Review 5.  Biology of human papillomaviruses.

Authors:  H R McMurray; D Nguyen; T F Westbrook; D J McAnce
Journal:  Int J Exp Pathol       Date:  2001-02       Impact factor: 1.925

Review 6.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

7.  Quantitative role of the human papillomavirus type 16 E5 gene during the productive stage of the viral life cycle.

Authors:  Sybil M Genther; Stephanie Sterling; Stefan Duensing; Karl Münger; Carol Sattler; Paul F Lambert
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

8.  Mucosal human papillomaviruses encode four different E5 proteins whose chemistry and phylogeny correlate with malignant or benign growth.

Authors:  Ignacio G Bravo; Angel Alonso
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

Review 9.  The E5 proteins.

Authors:  Daniel DiMaio; Lisa M Petti
Journal:  Virology       Date:  2013-05-31       Impact factor: 3.616

Review 10.  Papillomavirus E5: the smallest oncoprotein with many functions.

Authors:  Aldo Venuti; Francesca Paolini; Lubna Nasir; Annunziata Corteggio; Sante Roperto; Maria S Campo; Giuseppe Borzacchiello
Journal:  Mol Cancer       Date:  2011-11-11       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.